drug
LYT-200
Phase 2updated 3mo agoby Gallop Oncology Inc
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying LYT-200
- phase1A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
- phase2LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 46m ago
Found something off?
comments(0)
5-min edit window · permanent after that